Revenue ₹213 Cr (+27.27% YoY)
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Fredun Pharmaceuticals LtdFredun Pharmaceuticals delivered a strong Q4 FY26 with revenue of ₹213 crore (+27% YoY), EBITDA of ₹29.1 crore (+67%...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.
Q4 FY26
15 May 2026
Revenue ₹213 Cr (+27.27% YoY)
Fredun Pharmaceuticals delivered a strong Q4 FY26 with revenue of ₹213 crore (+27% YoY), EBITDA of ₹29.1 crore (+67% YoY), and PAT of ₹11.1 crore (+56% YoY).
bullish
high
Scorecard starts after historical backfill
Read full analysis →
Q3 FY26
14 Feb 2026
Revenue ₹161 Cr (+57% YoY)
Fredun Pharmaceuticals delivered a strong Q3 FY26 with revenue of ₹160.92 crore (+57% YoY), EBITDA of ₹26.34 crore (+99% YoY), and PAT of ₹10.48 crore (+96% YoY).
bullish
high
Scorecard starts after historical backfill
Read full analysis →